Skip to main content
OpenTrials
Completed

NCT Number: NCT03092700

Pulmonary Rehabilitation, Dyspnoea and Emotional Cognition in COPD

To evaluate whether pulmonary rehabilitation improves emotional cognition, using facial emotions recognition and smile production, by improving the emotional dimension of dyspnoea in patients with chronic obstructive pulmonary disease (COPD).To evaluate whether pulmonary rehabilitation improves emotional cognition, using facial emotions recognition and smile production, by improving the emotional dimension of dyspnoea in patients with chronic obstructive pulmonary disease (COPD).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COPD Affective Symptoms Behavior Behavioral Symptoms Chronic Disease Disease Attributes Dyspnea Emotional Disturbances Lung Diseases Lung Diseases, Obstructive Pathologic Processes Pathological Conditions, Signs and Symptoms Pulmonary Disease, Chronic Obstructive Rehabilitation; Tobacco Use Respiration Disorders Respiratory Tract Diseases Signs and Symptoms Signs and Symptoms, Respiratory Tobacco Use

Age range

40 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Centre d'Investigation Clinique Paris Est, Groupe Hospitalier Pitié-Salpêtrière

Paris, 75013, France

About this study

The aim of the study will be to evaluate the effect of pulmonary rehabilitation on dyspnoea emotional component and on emotional cognition. It will add a better understanding of the mechanisms of pulmonary rehabilitation on dyspnoea.

Patients with COPD will be included before starting a pulmonary rehabilitation and be evaluated with questionnaires (including the Multidimensional Dyspnea Profile, and quality of life questionnaires), emotional cognition (at rest and right after an endurance test, using some short movies sequences and pictures of faces expressing some well defined emotions) and smile production analysis.

After having followed a pulmonary rehabilitation, the same evaluation will be realised and results will be compared before and after the intervention.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • COPD patients with pulmonary rehabilitation indication, hospitalized in Department of Pulmonary Diseases in La Pitié-Salpêtrière, Paris, France.
  • Age of 40 at least.

Exclusion criteria

  • Facial paralysis
  • Neuromuscular disease
  • Contraindication for pulmonary rehabilitation
  • Severe depression syndrom or psychiatric disease
  • Drug use
  • Impaired vision
  • Higher functions disorders (Mini Mental Score Examination < 26)
  • Severe obesity (BMI>40kg/m²)

Treatment and study plan

Primary outcomes

  1. emotional cognition

    Time frame: 6 weeks

    Emotional cognition in patients with chronic dyspnoea using time to recognize some emotions on short movies and pictures of facial emotions.

Secondary outcomes

  1. Correlation between physical improvement, quality of life improvement and time to recognize facial emotions.

    Time frame: 6 weeks

    Correlations

  2. Correlations between physical improvement and production of the smile.

    Time frame: 6 weeks

    Correlations

Sponsors and collaborators

Lead sponsor

Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil

Other

Registry information

Official study title

Effects of Pulmonary Rehabilitation on Dyspnoea Affective Dimension and Emotional Cognition in Patients With Chronic Obstructive Pulmonary Disease

Acronym: READ-COG BPCO

Important dates

Study start
2017
Primary completion
2017
Study completion
2017
First posted
Mar 28, 2017
Registry last updated
Feb 24, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.